Dynavax announced grant to scale up CpG 1018 adjuvant capacity to support global COVID-19 response
On Aug. 13, 2020, Dynavax Technologies announced a grant from the Bill & Melinda Gates Foundation of $3.4…
-
-
Novavax and SK bioscience announced collaboration for Novavax COVID-19 vaccine candidate
On Aug. 13, 2020, Novavax and SK bioscience announced a development and supply agreement for the antigen component…
-
Baxter obtained FDA Emergency Use Authorizations for HF20 set and ST set used in CRRT during Covid-19 pandemic
On Aug. 12, 2020, Baxter announced it had received Emergency Use Authorizations (EUAs) from the FDA for the…
-
Pfizer and BioNTech announced publication of peer-reviewed data from phase 1/2 study of mRNA-based vaccine candidate
On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
-
Bio-Techne announced new SARS-CoV-1/2 spike RBD LlaMABody recombinant antibody that blocks viral entry
On Aug. 11, 2020, Bio-Techne announced the release of the SARS-CoV-1/2 Spike RBD LlaMABody Recombinant Antibody, which binds…
-
LabCorp to perform antibody test at no charge to accelerate COVID-19 blood plasma donation
On Aug. 11, 2020, LabCorp announced details of a no charge antibody testing program in response to federal…
-
Biotechnology | HIV | Infectious Disease | Medicine | Therapeutics | Vaccine | WHO
China National Medical Products Administration approved Truvada for HIV pre-exposure prophylaxis
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
-
Hologic launched validated pooling protocol for COVID-19 testing
On Aug. 11, 2020, Hologic announced that it has validated use of its Aptima® and Panther Fusion® molecular…
-
Moderna announced supply agreement with U.S. Government for initial 100 million doses of mRNA vaccine against COVID-19
On Aug. 11, 2020, Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273 as…
-
Clinical trials of monoclonal antibodies to prevent COVID-19 began enrollment
On Aug. 10, 2020, two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs)…
-
Gilead submited New Drug Application to FDA for Veklury (Remdesivir) for treatment of COVID-19
On Aug. 10, 2020, Gilead Sciences announced that it had submitted a New Drug Application (NDA) to the…
-
Cors Blood Registry by Generate Life Sciences partnered with Nantwest to develop COVID-19 treatment
On Aug. 10, 2020, CBR by Generate Life Sciences, the world’s largest private newborn stem cell bank, and…
-
Omeros reported recovery and durvival of all patients in study evaluating narsoplimab fortreatment of COVID-19-associated Acute Respiratory Distress Syndrome
On Aug. 10, 2020, Omeros reported the results of a compassionate-use study evaluating narsoplimab, Omerosﾒ investigational human monoclonal…
-
Intravacc received US NIH/NIAID contract to develop Enterovirus D68 Vaccine
On Aug. 9, 2020, Intravacc announced that it had been awarded a contract with base and options that…
-
OpGen began co-marketing COVID-19 antibody test kit
On Aug. 9, 2020, OpGen announced that it had commenced marketing and promotion, on a non-exclusive basis, of…
-
Scientists revealed structural details of spike protein used in leading COVID-19 vaccine
On Aug. 7, 2020, scientists at Scripps Research announced they had obtained high-resolution, atomic-scale details of the structure…
-
Novavax and Takeda announced collaboration for Novavax COVID-19 vaccine candidate in Japan
On Aug. 7, 2020, Novavax and Takeda Pharmaceutical announced a partnership for the development, manufacturing and commercialization of…
-
Pfizer announced agreement with Gilead to manufacture remdesivir for treatment of COVID-19
On Aug. 7, 2020, Pfizer announced a multi-year agreement with Gilead Sciences to manufacture and supply Gileadﾒs investigational…
-
HKUMed discovered that acute SARS-CoV-2 infection impairs human immune defences
On Aug. 6, 2020, researchers at the AIDS Institute, Department of Microbiology and State Key Laboratory of Emerging…
-
Novavax signed COVID-19 vaccine supply deal with India’s Serum Institute
On Aug. 6, 2020, Novavax announced it had entered a supply and license agreement with the Serum Institute…
-
FDA approved two emergency INDs for COVID-19 outpatient therapy
On Aug. 6, 2020, Organicell Regenerative Medicine, a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies,…
-
VBI Vaccines awarded up to CAD$56 million contribution from Canadian Government to accelerate Coronavirus vaccine development
On Aug. 5, 2020, Variation Biotechnologies, an Ottawa-based subsidiary of VBI Vaccines, announced that it had been awarded…
-
NIH began clinical trial testing remdesivir plus interferon beta-1a for COVID-19 treatment
On Aug. 5, 2020, a randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen…
-
NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoring
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
-
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
-
Tecan’s automation technology leveraged by Thermo Fisher to scale-up COVID-19 testing globally
On Aug. 5, 2020, the Tecan Group and Thermo Fisher Scientific announced a collaboration to enable scaled-up COVID-19…
-
BioNTech and Fosun Pharma announced start of clinical trial of mRNA-based COVID-19 vaccine candidate in China
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
-
Johnson & Johnson announces agreement with US Government for 100 million doses of investigational COVID-19 vaccine
On Aug. 5, 2020, Johnson & Johnson announced a $1 billion agreement with the U.S. government for the…
-
AXIM Biotechnologies applied for FDA Emergency Use Approval for high throughput, neutralizing antibody diagnostic test for COVID-19
On Aug. 5, 2020, AXIM Biotechnologies announced the development, patent filing and Emergency Use Approval (EUA) filing of…
-
Cancer Research Institute awarded $302 million in grants and fellowships
On Aug. 5, 2020, the Cancer Research Institute (CRI), a U.S. nonprofit organization dedicated to the discovery and…
